Associate Professor Glen Reid

Associate Professor
Asbestos Diseases Research Institute, Concord Clinical School

C22 - Concord Hospital
The University of Sydney
NSW 2006 Australia

T: +61 2 9767 9800
F: +61 2 9767 9860

Research interests

As Senior Research Scientist at the Asbestos Diseases Research Insitute I lead research focused on translational studies of malignant pleural mesothelioma, an asbestos-related cancer for which Australia has one of the worldÂ’s highest incidence rates. My research aims to identify new molecular biomarkers and novel therapeutic targets for this disease.


Asbestos-related diseases; Malignant mesothelioma; Cancer; Molecular biology


2014 | 2013 | 2012 | 2011 | 2010


  • Linton, A., Cheng, Y., Griggs, K., Kirschner, M., Gattani, S., Srikaran, S., Chuan-Hao Kao, S., McCaughan, B., Klebe, S., van Zandwijk, N., Reid, G. (2014), An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma. British Journal of Cancer. 110(2), 510-519. [Abstract]
  • Cheng, N., van Zandwijk, N., Reid, G. (2014), Cilengitide inhibits attachment and invasion of malignant pleural mesothelioma cells through antagonism of integrins αvβ3 and αvβ5. PloS One. 9(3), e90374. [Abstract]


  • Wright, C., Kirschner, M., van Zandwijk, N., Reid, G. (2013), Does miR-1 play a role in malignant pleural mesothelioma development and progression?. Chest. , 1971. [Abstract]
  • Reid, G., Pel, M., Kirschner, M., Cheng, Y., Mugridge, N., Weiss, J., Williams, M., Wright, C., Edelman, J., Vallely, M., McCaughan, B., Klebe, S., Brahmbhatt, H., Macdiarmid, J., van Zandwijk, N. (2013), Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma. Annals of Oncology. 24(12), 3128-3135. [Abstract]
  • Cheng, Y., Kirschner, M., Cheng, N., Gattani, S., Klebe, S., Edelman, J., Vallely, M., McCaughan, B., Jin, H., van Zandwijk, N., Reid, G. (2013), ZIC1 Is Silenced and Has Tumor Suppressor Function in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 8(10), 1317-1328. [Abstract]
  • Wright, C., Kirschner, M., Cheng, Y., O'Byrne, K., Gray, S., Schelch, K., Hoda, M., Klebe, S., McCaughan, B., van Zandwijk, N., Reid, G. (2013), Long Non Coding RNAs (lncRNAs) Are Dysregulated in Malignant Pleural Mesothelioma (MPM). PloS One. 8(8), e70940. [Abstract]
  • Kirschner, M., Edelman, J., Kao, S., Vallely, M., van Zandwijk, N., Reid, G. (2013), The Impact of Hemolysis on Cell-Free microRNA Biomarkers. Frontiers in Genetics. 4, 94. [Abstract]
  • Kirschner, M., van Zandwijk, N., Reid, G. (2013), Cell-free microRNAs: potential biomarkers in need of standardized reporting. Frontiers in Genetics. 4, 56. [Abstract]


  • Kirschner, M., Cheng, Y., Badrian, B., Kao, S., Creaney, J., Edelman, J., Armstrong, N., Vallely, M., Musk, A., Robinson, B., McCaughan, B., Klebe, S., Mutsaers, S., van Zandwijk, N., Reid, G. (2012), Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 7(7), 1184-1191. [Abstract]
  • Lasham, A., Samuel, W., Cao, H., Patel, R., Mehta, R., Stern, J., Reid, G., Woolley, A., Miller, L., Black, M., Shelling, A., Print, C., Braithwaite, A. (2012), YB-1, the E2F Pathway, and Regulation of Tumor Cell Growth. Journal of the National Cancer Institute. 104(2), 133-46. [Abstract]


  • Reid, G., Kirschner, M., van Zandwijk, N. (2011), Circulating microRNAs: Association with disease and potential use as biomarkers. Critical reviews in oncology/hematology. 80(2), 193-208. [Abstract]
  • Kao, S., Klebe, S., Henderson, D., Reid, G., Chatfield, M., Armstrong, N., Yan, T., Vardy, J., Clarke, S., van Zandwijk, N., McCaughan, B. (2011), Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy. Journal of Thoracic Oncology. 6(11), 1923-1929. [Abstract]
  • Li, Y., Revalde, J., Reid, G., Paxton, J. (2011), Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells. Cancer chemotherapy and pharmacology. 68(0), 603-10. [Abstract]
  • Kao, S., Reid, G., van Zandwijk, N., Henderson, D., Klebe, S. (2011), Molecular biomarkers in malignant mesothelioma: state of the art. Pathology. 43(3), 201-112. [Abstract]
  • Kao, S., Lee, K., Armstrong, N., Clarke, S., Vardy, J., van Zandwijk, N., Reid, G., Burn, J., McCaughan, B., Henderson, D., Klebe, S. (2011), Validation of tissue microarray technology in malignant pleural mesothelioma. Pathology. 43(2), 128-132. [Abstract]
  • Herbert, M., Coppieters, N., Lasham, A., Cao, H., Reid, G. (2011), The importance of RT-qPCR primer design for the detection of siRNA-mediated mRNA silencing. BMC research notes. 4(1), 148. [Abstract]
  • Kirschner, M., Kao, S., Edelman, J., Armstrong, N., Vallely, M., van Zandwijk, N., Reid, G. (2011), Haemolysis during Sample Preparation Alters microRNA Content of Plasma. PloS One. 6(9), e24145. [Abstract]


  • Li, Y., Revalde, J., Reid, G., Paxton, J. (2010), Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer. Drug Metabolism Reviews. 42(4), 590-611. [Abstract]
  • Kao, S., Reid, G., Lee, K., Vardy, J., Clarke, S., van Zandwijk, N. (2010), Malignant Mesothelioma. Internal Medicine Journal. 40(11), 742-750. [Abstract]
  • Lasham, A., Herbert, M., Coppieters 't Wallant, N., Patel, R., Feng, S., Eszes, M., Cao, H., Reid, G. (2010), A rapid and sensitive method to detect siRNA-mediated mRNA cleavage in vivo using 5' RACE and a molecular beacon probe. Nucleic Acids Research. 38(3), e19. [Abstract]